Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
You must be a Standard 1 Year member to access this content.
Leerink Partners is acting as exclusive financial advisor and Gibson, Dunn & Crutcher LLP is acting as legal counsel to Rain. Goodwin Procter LLP is acting...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
You must be a Standard 1 Year member to access this content.
Kyowa Kirin was represented by Goldman Sachs Japan Co., Ltd. as financial advisor and Morrison & Foerster LLP. as legal advisor. Orchard Therapeutics was represented by...
You must be a Standard 1 Year member to access this content.
Goodwin advised Pulsic on the sale. Cadence Design Systems, Inc. (NasdaqGS:CDNS) completed the acquisition of Pulsic Limited on May 22, 2023. The addition of Pulsic further strengthens...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Insempra on the deal. Insempra announced its strategic investment into Solena Materials Ltd (“Solena”) a synthetic biology company. Solena, a spin-out from Imperial College...
You must be a Standard 1 Year member to access this content.
Goodwin advised SV Health, Jeito and Samsara BioCapital on the deal. SV Health, Jeito and Samsara BioCapital led a $65 million Series A Financing of EyeBio. EyeBio...
You must be a Standard 1 Year member to access this content.
